United States (National)
Not enough data
Pearl Steinzor's coverage predominantly focuses on healthcare and pharmaceuticals, with a significant emphasis on citing data and expert commentary. She would likely be receptive to pitches offering access to recent studies or medical research findings in the fields of cancer, psoriasis, reproductive care, asthma, rare diseases, digital health, and precision medicine.
Given her focus on scientific themes and reliance on expert commentary along with cited data sources for her articles, Pearl is likely to respond well to pitches that offer credible experts who can provide insights into the latest medical research developments or those who have first-hand experience in dealing with the discussed healthcare topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Pearl Steinzor
Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients with multiple myeloma.
By: Pearl Steinzor
At an Institute for Value-Based Medicine® event held in Aurora, Colorado, experts discussed strategies to improve patient outcomes and manage health care costs in neurological diseases.
By: Pearl Steinzor
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program, shares findings on innovative strategies to improve access to new therapies in pediatric cancer.
The Community Oncology Alliance (COA) meetings featured expert discussions around the evolving landscape of oncology care and health care reform.
By: Pearl Steinzor
Keith Ferdinand, MD, professor of medicine, Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine, discusses the interconnected condition of cardiovascular-kidney-metabolic (CKM) syndrome, which includes obesity, diabetes, chronic kidney disease, and cardiovascular disease.
By: Pearl Steinzor
Two posters presented at the 2024 American Society of Hematology meeting evaluated overall survival and cost-offset of covalent Bruton’s tyrosine kinase inhibitors (cBTKis) in patients with chronic lymphocytic leukemia (CLL).
By: Pearl Steinzor
Study identifies underutilization of testing, with disparities by race and sex.
By: Pearl Steinzor
Understanding postural orthostatic tachycardia syndrome is important in order to improve prevention and outcomes.
By: Pearl Steinzor
Key Takeaways Financial toxicity persists, with 17% of patients avoiding follow-up care due to high costs, impacting quality of life and treatment decisions.
Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.
(833) 317-6278 
